{"id":"https://openalex.org/W137145377","doi":null,"title":"The role of VEGF and other parameters in tracking the clinical course in metronomic chemotherapy.","display_name":"The role of VEGF and other parameters in tracking the clinical course in metronomic chemotherapy.","publication_year":2013,"publication_date":"2013-01-01","ids":{"openalex":"https://openalex.org/W137145377","mag":"137145377","pmid":"https://pubmed.ncbi.nlm.nih.gov/23613412"},"language":"en","primary_location":{"id":"pmid:23613412","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23613412","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of B.U.ON. : official journal of the Balkan Union of Oncology","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"D Ekinci","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"D Ekinci","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016947883","display_name":"Diren Ekici","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I197907453","display_name":"Akdeniz University","ror":"https://ror.org/01m59r132","country_code":"TR","type":"education","lineage":["https://openalex.org/I197907453"]}],"countries":["TR"],"is_corresponding":false,"raw_author_name":"D Ekici","raw_affiliation_strings":["Department of Medical Oncology, Akdeniz University Faculty of Medicine, Antalya, Turkey"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Akdeniz University Faculty of Medicine, Antalya, Turkey","institution_ids":["https://openalex.org/I197907453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000442883","display_name":"Ay\u015feg\u00fcl Karg\u0131","orcid":"https://orcid.org/0000-0003-4797-7313","observed_orcids":["https://orcid.org/0000-0003-4797-7313"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A Kargi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014233084","display_name":"Arzu Didem Yal\u00e7\u0131n","orcid":"https://orcid.org/0000-0002-0615-5279","observed_orcids":["https://orcid.org/0000-0002-0615-5279"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A D Yalcin","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014233084","display_name":"Arzu Didem Yal\u00e7\u0131n","orcid":"https://orcid.org/0000-0002-0615-5279","observed_orcids":["https://orcid.org/0000-0002-0615-5279"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A Didem Yalcin","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5051103188","display_name":"Burhan Sava\u015f","orcid":"https://orcid.org/0009-0000-0815-3237","observed_orcids":["https://orcid.org/0009-0000-0815-3237"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"B Savas","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.11,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":{"value":0.42893476,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":96},"biblio":{"volume":"18","issue":"1","first_page":"245","last_page":"52"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.0019000000320374966,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11469","display_name":"Lymphatic System and Diseases","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/vascular-endothelial-growth-factor","display_name":"vascular endothelial growth factor","score":0.8840000033378601},{"id":"https://openalex.org/keywords/metronomic-chemotherapy","display_name":"metronomic chemotherapy","score":0.9150000214576721},{"id":"https://openalex.org/keywords/serum-vegf-levels","display_name":"serum VEGF levels","score":0.9049999713897705},{"id":"https://openalex.org/keywords/bevacizumab","display_name":"bevacizumab","score":0.9229999780654907},{"id":"https://openalex.org/keywords/anti-angiogenic-therapy","display_name":"anti-angiogenic therapy","score":0.9649999737739563},{"id":"https://openalex.org/keywords/metastatic-colorectal-cancer","display_name":"metastatic colorectal cancer","score":0.8690000176429749},{"id":"https://openalex.org/keywords/cyclophosphamide","display_name":"cyclophosphamide","score":0.8700000047683716},{"id":"https://openalex.org/keywords/methotrexate","display_name":"methotrexate","score":0.9890000224113464},{"id":"https://openalex.org/keywords/folfiri","display_name":"FOLFIRI","score":0.9449999928474426},{"id":"https://openalex.org/keywords/treatment-response-monitoring","display_name":"treatment response monitoring","score":0.5590000152587891},{"id":"https://openalex.org/keywords/metastatic-cancer","display_name":"metastatic cancer","score":0.6420000195503235}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8945552110671997},{"id":"https://openalex.org/C2777802072","wikidata":"https://www.wikidata.org/wiki/Q413299","display_name":"Bevacizumab","level":3,"score":0.8702633380889893},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.7131505608558655},{"id":"https://openalex.org/C2776705615","wikidata":"https://www.wikidata.org/wiki/Q1389369","display_name":"FOLFIRI","level":5,"score":0.694542646408081},{"id":"https://openalex.org/C2777025900","wikidata":"https://www.wikidata.org/wiki/Q29725","display_name":"Vascular endothelial growth factor","level":3,"score":0.6489511728286743},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6345864534378052},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5635672807693481},{"id":"https://openalex.org/C2776755627","wikidata":"https://www.wikidata.org/wiki/Q408524","display_name":"Cyclophosphamide","level":3,"score":0.4877201020717621},{"id":"https://openalex.org/C167734588","wikidata":"https://www.wikidata.org/wiki/Q4356503","display_name":"VEGF receptors","level":2,"score":0.46477821469306946},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.45650017261505127},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.34701550006866455},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.31111714243888855},{"id":"https://openalex.org/C2780962732","wikidata":"https://www.wikidata.org/wiki/Q422327","display_name":"Oxaliplatin","level":4,"score":0.21667510271072388}],"mesh":[{"descriptor_ui":"D000068258","descriptor_name":"Bevacizumab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002166","descriptor_name":"Camptothecin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D002166","descriptor_name":"Camptothecin","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D002955","descriptor_name":"Leucovorin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D003520","descriptor_name":"Cyclophosphamide","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005472","descriptor_name":"Fluorouracil","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008727","descriptor_name":"Methotrexate","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000098","qualifier_name":"blood supply","is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014408","descriptor_name":"Biomarkers, Tumor","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020533","descriptor_name":"Angiogenesis Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D042461","descriptor_name":"Vascular Endothelial Growth Factor A","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D059250","descriptor_name":"Administration, Metronomic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:23613412","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23613412","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of B.U.ON. : official journal of the Balkan Union of Oncology","raw_type":"Journal Article"},{"id":"mag:137145377","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23613412","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":18,"referenced_works":["https://openalex.org/W304295984","https://openalex.org/W1579641819","https://openalex.org/W1982388744","https://openalex.org/W2000292756","https://openalex.org/W2003080165","https://openalex.org/W2009968499","https://openalex.org/W2012852444","https://openalex.org/W2032882287","https://openalex.org/W2075549113","https://openalex.org/W2081633887","https://openalex.org/W2086992314","https://openalex.org/W2088571368","https://openalex.org/W2093498435","https://openalex.org/W2139097129","https://openalex.org/W2152290175","https://openalex.org/W2154922612","https://openalex.org/W2439305589","https://openalex.org/W2460779682"],"related_works":["https://openalex.org/W2591243366","https://openalex.org/W2098122003","https://openalex.org/W2002623071","https://openalex.org/W2053258375","https://openalex.org/W657828613","https://openalex.org/W2337865916","https://openalex.org/W2128011232","https://openalex.org/W4249378873","https://openalex.org/W1992181975","https://openalex.org/W2070439776"],"abstract_inverted_index":{"PURPOSE:":[0],"The":[1,26],"purpose":[2],"of":[3,11,62,71,85,164,167],"this":[4],"study":[5,27],"was":[6,54],"to":[7,103,119],"investigate":[8],"the":[9,110,120,128,145,165],"effect":[10],"metronomic":[12,47,104,135],"chemotherapy":[13,53,105,136],"on":[14,134],"serum":[15,115],"vascular":[16],"endothelial":[17],"growth":[18],"factor":[19],"(VEGF)":[20],"levels":[21,70,84,101,117,138,148,158],"in":[22,59],"cancer":[23,31],"patients.":[24,67],"METHODS:":[25],"included":[28],"11":[29],"metastatic":[30,64],"patients":[32,86,133],"who":[33],"received":[34],"daily":[35],"50":[36],"mg":[37,42],"cyclophosphamide":[38],"and":[39,75,89,96],"biweekly":[40],"5":[41,76],"methotrexate":[43],"per":[44],"os":[45],"as":[46,56],"chemotherapy.":[48],"Bevacizumab":[49],"together":[50],"with":[51,109,127,152],"FOLFIRI":[52],"administered":[55],"anti-angiogenic":[57,168],"treatment":[58,93],"another":[60],"group":[61],"16":[63],"colorectal":[65],"carcinoma":[66],"Furthermore,":[68],"VEGF":[69,83,100,116,137,147,157],"10":[72],"healthy":[73,111,129],"individuals":[74],"cord":[77],"blood":[78],"samples":[79],"served":[80],"for":[81,162],"comparisons.":[82],"before":[87],"therapy":[88],"3":[90],"months":[91],"after":[92],"were":[94,106,123],"analyzed":[95],"compared.":[97],"RESULTS:":[98],"Serum":[99,156],"prior":[102,118],"higher":[107,125],"compared":[108,126],"controls":[112,130],"(p=0.0001).":[113],"Similarly,":[114],"bevacizumab-based":[121],"chemoimmunotherapy":[122],"significantly":[124,150],"(p=0.005).":[131],"In":[132],"showed":[139],"non":[140],"significant":[141],"decrease":[142],"(p=0.075).":[143],"On":[144],"contary,":[146],"decreased":[149],"(p=0.002)":[151],"bevacizumab":[153],"treatment.":[154],"CONCLUSION:":[155],"may":[159],"be":[160],"used":[161],"assessing":[163],"efficacy":[166],"therapies.":[169]},"counts_by_year":[{"year":2018,"cited_by_count":2},{"year":2016,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}